This is my fifth published collection of biopharma haiku. I hope you enjoy them!
Elizabeth Holmes
Next nanotainer: prison
Crook, plain and simple
Holmes and Balwani
Deceitful duo facing
20 years hard time
No due diligence
Theranos fooled investors
Too good to be true
Novartis misled
Cohen contacts extensive
Paid for influence
ACA attack
Pre-existing conditions
Most of us have them
Republican plan
Take away their insurance
Condemn poor to die
AI will solve all
Kool-aid drinkers believe this
Delusional folks
FDA re-org
Cut headcount thirty percent?
Watch approvals drop
Antibiotics
Novartis ditches market
Who will create them?
Big IPO surge
Biotechs inhaling money
Overvalued firms
China ambitions large
Major player in drug space?
Only time will tell
I-O explosion
Competition for patients
Bottleneck coming
Shkreli in prison
Smug jerk got big comeuppance
Who is laughing now?
CAR-T therapies
Good start, but much work ahead
Optimization
Diabetes war
Oral GLP-1 drugs
The battle in on
Reefer rep rising
Cannabinoid approval
First from FDA
Ex-Puma exec
Insider trading jail term
Greed made him do it
Hype again beats facts
“Right to try” legislation
Bad news for patients
Merck and BMS
Locked up in mortal combat
I-O leadership
Aging research pact
Abbvie-Calico tie-up
Long road to new drugs
Celgene rep damaged
Former industry darling
Fallen on hard times
Roivant restructures
Success has been elusive
All “vant” all the time
Drug prices way too high
Trump promised to lower them
Sounds good, but more lies
Surrogate endpoints
Best way to track responses?
Real or illusion
Atul Gawande
Buffett, Dimon, and Bezos
Well-chosen leader
Liquid biopsy
How will it prove its value?
No false negatives
Sarepta results
Much better data this time
Can they save the boys?
Biotech deals soar
Too many to keep track of
Most will crash and burn
Another big trend
Personalized medicine
Prime time still years off
Cancer drug testing
Organ chips and organoids
Paint me skeptical
Rare disease drugs hot
Still command premium prices
Sky almost the limit
Opioid crisis
Blather, drivel, talk, twaddle
Solve problem instead
PARP inhibitors
Ovarian cancer drugs
Good news for patients
Alzheimer’s disease
Treatments still failing big time
Need new approaches
Have skin in the game
High-deductible health plan
Ensures crushing debt
ACA damaged
Medical bills piling up
Thank Republicans
HPV cancers
Incidence soaring in men
Vaccinate boys now
Thalassemia,
Gene therapy promising
Hemophilia
Celgene hissy fit
Ozanimod fiasco
Receptos gets blame
CRISPR news update
Lawsuits overshadow all
Refocus science
3D cell printing
Capacity is expanding
Some day new organs
Home DNA tests
Results frequently are wrong
Consumer nightmare
No posts